Health News-RSS Feeds

US FDA approves first drug for fatty liver disease NASH

March 14, 2024 - 8:24pm

Reuters was first to report on the FDA approving Madrigal Pharmaceuticals’ drug Rezdiffra, an oral drug to treat a fatty liver disease known as non-alcoholic steatohepatitis (NASH). The approval was the first of its kind. 

The post US FDA approves first drug for fatty liver disease NASH appeared first on Reuters News Agency.

Novo Nordisk says experimental drug amycretin show 13% weight loss in trial 

March 7, 2024 - 7:34pm

Reuters was first to report on the early trial data for Novo Nordisk’s highly anticipated experimental drug amycretin which showed that participants had a weight loss of 13.1% after 12 weeks, prompting the company’s shares to rise to record highs and placing it above Tesla by market valuation. 

The post Novo Nordisk says experimental drug amycretin show 13% weight loss in trial  appeared first on Reuters News Agency.

Major Bayer shareholder Harris backs CEO’s focus on internal restructuring 

March 7, 2024 - 7:26pm

Reuters exclusively reported that major Bayer shareholder Harris Associates came out in strong support of the drugmaker’s decision to suspend work on breaking up the diversified group, giving some breathing room to its embattled CEO. 

The post Major Bayer shareholder Harris backs CEO’s focus on internal restructuring  appeared first on Reuters News Agency.

Eli Lilly could launch obesity drug in India next year

February 28, 2024 - 6:25pm

Reuters exclusively reported that U.S. drugmaker Eli Lilly LLY.N expects to launch Mounjaro, its blockbuster diabetes drug and wildly popular obesity treatment, in India as early as next year after it clears an ongoing regulatory review. 

The post Eli Lilly could launch obesity drug in India next year appeared first on Reuters News Agency.

ECB sounds out lenders on exposure to Spanish drugmaker Grifols 

January 17, 2024 - 11:29pm

Reuters exclusively reported that the European Central Bank was asking banks to detail their exposure to Spanish drugmaker Grifols and a network of companies linked to the founding family, days after the Barcelona-based business was accused of manipulating its financial accounts by a short-seller. The story also revealed how supervisors were concerned that the huge drop in Grifols’ share price could require family-connected companies which have borrowed using Grifols stock as collateral to post more margin. Grifols denies all the allegations made by Gotham City Research, the short-seller. The story was picked up by Bloomberg, Spain’s state-owned news agency, EFE, and made it into several newspapers including Expansion, El Mundo and the front page of business daily Cinco Dias. 

The post ECB sounds out lenders on exposure to Spanish drugmaker Grifols  appeared first on Reuters News Agency.

US FDA finds control lapses at Moderna manufacturing plant 

December 15, 2023 - 3:12pm

Reuters exclusively reported that U.S. drug regulators in September found quality control lapses at Moderna’s (MRNA.O) main factory including with equipment used to manufacture drug substance for its COVID-19 vaccine. 

The post US FDA finds control lapses at Moderna manufacturing plant  appeared first on Reuters News Agency.